Cargando…
Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs
Identifying causal genes at GWAS loci can help pinpoint targets for therapeutic interventions. Expression studies can disentangle such loci but signals from expression quantitative trait loci (eQTLs) often fail to colocalize—which means that the genetic control of measured expression is not shared w...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511363/ https://www.ncbi.nlm.nih.gov/pubmed/37640912 http://dx.doi.org/10.1007/s00439-023-02590-w |
_version_ | 1785108122430341120 |
---|---|
author | Willett, Julian Daniel Sunday Lu, Tianyuan Nakanishi, Tomoko Yoshiji, Satoshi Butler-Laporte, Guillaume Zhou, Sirui Farjoun, Yossi Richards, J. Brent |
author_facet | Willett, Julian Daniel Sunday Lu, Tianyuan Nakanishi, Tomoko Yoshiji, Satoshi Butler-Laporte, Guillaume Zhou, Sirui Farjoun, Yossi Richards, J. Brent |
author_sort | Willett, Julian Daniel Sunday |
collection | PubMed |
description | Identifying causal genes at GWAS loci can help pinpoint targets for therapeutic interventions. Expression studies can disentangle such loci but signals from expression quantitative trait loci (eQTLs) often fail to colocalize—which means that the genetic control of measured expression is not shared with the genetic control of disease risk. This may be because gene expression is measured in the wrong cell type, physiological state, or organ. We tested whether Mendelian randomization (MR) could identify genes at loci influencing COVID-19 outcomes and whether the colocalization of genetic control of expression and COVID-19 outcomes was influenced by cell type, cell stimulation, and organ. We conducted MR of cis-eQTLs from single cell (scRNA-seq) and bulk RNA sequencing. We then tested variables that could influence colocalization, including cell type, cell stimulation, RNA sequencing modality, organ, symptoms of COVID-19, and SARS-CoV-2 status among individuals with symptoms of COVID-19. The outcomes used to test colocalization were COVID-19 severity and susceptibility as assessed in the Host Genetics Initiative release 7. Most transcripts identified using MR did not colocalize when tested across cell types, cell state and in different organs. Most that did colocalize likely represented false positives due to linkage disequilibrium. In general, colocalization was highly variable and at times inconsistent for the same transcript across cell type, cell stimulation and organ. While we identified factors that influenced colocalization for select transcripts, identifying 33 that mediate COVID-19 outcomes, our study suggests that colocalization of expression with COVID-19 outcomes is partially due to noisy signals even after following quality control and sensitivity testing. These findings illustrate the present difficulty of linking expression transcripts to disease outcomes and the need for skepticism when observing eQTL MR results, even accounting for cell types, stimulation state and different organs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00439-023-02590-w. |
format | Online Article Text |
id | pubmed-10511363 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-105113632023-09-22 Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs Willett, Julian Daniel Sunday Lu, Tianyuan Nakanishi, Tomoko Yoshiji, Satoshi Butler-Laporte, Guillaume Zhou, Sirui Farjoun, Yossi Richards, J. Brent Hum Genet Original Investigation Identifying causal genes at GWAS loci can help pinpoint targets for therapeutic interventions. Expression studies can disentangle such loci but signals from expression quantitative trait loci (eQTLs) often fail to colocalize—which means that the genetic control of measured expression is not shared with the genetic control of disease risk. This may be because gene expression is measured in the wrong cell type, physiological state, or organ. We tested whether Mendelian randomization (MR) could identify genes at loci influencing COVID-19 outcomes and whether the colocalization of genetic control of expression and COVID-19 outcomes was influenced by cell type, cell stimulation, and organ. We conducted MR of cis-eQTLs from single cell (scRNA-seq) and bulk RNA sequencing. We then tested variables that could influence colocalization, including cell type, cell stimulation, RNA sequencing modality, organ, symptoms of COVID-19, and SARS-CoV-2 status among individuals with symptoms of COVID-19. The outcomes used to test colocalization were COVID-19 severity and susceptibility as assessed in the Host Genetics Initiative release 7. Most transcripts identified using MR did not colocalize when tested across cell types, cell state and in different organs. Most that did colocalize likely represented false positives due to linkage disequilibrium. In general, colocalization was highly variable and at times inconsistent for the same transcript across cell type, cell stimulation and organ. While we identified factors that influenced colocalization for select transcripts, identifying 33 that mediate COVID-19 outcomes, our study suggests that colocalization of expression with COVID-19 outcomes is partially due to noisy signals even after following quality control and sensitivity testing. These findings illustrate the present difficulty of linking expression transcripts to disease outcomes and the need for skepticism when observing eQTL MR results, even accounting for cell types, stimulation state and different organs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00439-023-02590-w. Springer Berlin Heidelberg 2023-08-28 2023 /pmc/articles/PMC10511363/ /pubmed/37640912 http://dx.doi.org/10.1007/s00439-023-02590-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Investigation Willett, Julian Daniel Sunday Lu, Tianyuan Nakanishi, Tomoko Yoshiji, Satoshi Butler-Laporte, Guillaume Zhou, Sirui Farjoun, Yossi Richards, J. Brent Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs |
title | Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs |
title_full | Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs |
title_fullStr | Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs |
title_full_unstemmed | Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs |
title_short | Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs |
title_sort | colocalization of expression transcripts with covid-19 outcomes is rare across cell states, cell types and organs |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511363/ https://www.ncbi.nlm.nih.gov/pubmed/37640912 http://dx.doi.org/10.1007/s00439-023-02590-w |
work_keys_str_mv | AT willettjuliandanielsunday colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans AT lutianyuan colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans AT nakanishitomoko colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans AT yoshijisatoshi colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans AT butlerlaporteguillaume colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans AT zhousirui colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans AT farjounyossi colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans AT richardsjbrent colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans |